European Medical Solutions

European Medical Solutions EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of European Medical Solutions (ALEMS.BR) as of Nov 10, 2026 is 2.68 M EUR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 4.32 M EUR — a change of -38.01% (lower).

EBITDA

2.68 MEUR

YoY

-38.01%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of European Medical Solutions is 2025 2.68 M EUR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of European Medical Solutions was 2024 4.32 M EUR. It decreases by -38.01% lower compared to the previous year.

The European Medical Solutions EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-12.51 M EUR
Jan 1, 2019
-15.61 M EUR
Jan 1, 2020
-721,000.00 EUR
Jan 1, 2021
1.96 M EUR
Jan 1, 2022
-3.09 M EUR
Jan 1, 2023
2.21 M EUR
Jan 1, 2024
4.32 M EUR
Jan 1, 2025
2.68 M EUR
The European Medical Solutions EBITDA history
YEAREBITDAYoY
2.68 MEUR-38.01%
4.32 MEUR+96.05%
2.21 MEUR-171.41%
-3.09 MEUR-257.39%
1.96 MEUR-372.12%
-721,000.00EUR-95.38%
-15.61 MEUR+24.70%
-12.51 MEUR+6.33%
-11.77 MEUR-2.95%
-12.13 MEUR+58.73%
-7.64 MEUR+76.93%
-4.32 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

European Medical Solutions Stock analysis

What does European Medical Solutions do? European Medical Solutions SA operates in the Health Care sector, specifically within the biotechnology industry. Headquartered in Liege, Belgium, the company is a clinical-stage biopharmaceutical entity focused on the research and development of immunotherapy treatments for environmental and food allergies. It currently employs 20 full-time staff members. The company listed its shares on the stock exchange on 11 May 2016, marking its entry into public markets while maintaining its focus on advancing novel therapeutic solutions in the allergy treatment space. European Medical Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about European Medical Solutions stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of European Medical Solutions is 2.68 M EUR in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of European Medical Solutions changed from 4.32 M EUR to 2.68 M EUR, representing a -38.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) European Medical Solutions since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s European Medical Solutions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — European Medical Solutions

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — European Medical Solutions